Bandingkan Harga & Kinerja DFI Retail Nusantara Tbk. (HERO) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan DFI Retail Nusantara Tbk. dan Brigit Biofarmaka Teknologi Tbk.: DFI Retail Nusantara Tbk. diperdagangkan di Rp340 (kapitalisasi pasar 1,42 T, volume 24 jam 9,4 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp242 (kapitalisasi pasar 164,65 M, volume 24 jam 177,6 rb). Perbedaan utamanya: DFI Retail Nusantara Tbk. jauh lebih besar — sekitar 8,6× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (177,6 rb vs 9,4 rb). Mana yang lebih baik tergantung tujuan investasimu.
| HERO | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 1,42 T | 164,65 M |
Volume | 9,4 rb | 177,6 rb |
Lot | 94 | 1,78 rb |
Perputaran | 3,19 jt | 42 jt |
Harga Rata-rata | 339,62 | 236,47 |
Nilai Transaksi | 3,19 jt | 42 jt |
Harga Ekuilibrium Indikatif | 336 | 242 |
Volume Ekuilibrium Indikatif | 2 | 500 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang DFI Retail Nusantara Tbk.
The company began its commercial operations in August 1972. Hero is Indonesia’s largest supermarket chain with a network of 66 supermarkets, consisting of 44 stores in Greater Jakarta and 22 stores in major regional cities. Supermarket operations account for about 90% of sales complemented by an array of retail formats including convenience stores, mini markets, and pharmacies. The company’s mission is to be the leading modern food retailer in Indonesia in terms of sales and profits, targeting the middle to upper income consumer segments where buying power is greatest. As the economy begins to gather strength, HERO has relatively aggressive expansion plans drawing upon its established brand, a reputation for fresh quality foods, friendly experienced staff, best service, a leading position in category and space management and efficient centralized distribution infrastructure. In 1998 the acquisition of a 32% effective interest in Hero by Dairy Farm International contributed significant international experience and expertise to the local knowledge and insight of Hero’s management as well as recognition of the potential of Indonesia as one of the most attractive growth markets in South East Asia over the medium long term.
Selengkapnya di halaman HERO →Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →
